Conference Speakers

KEYNOTE SPEAKERS

Speaker Talk
Prof. Mostafa A. El-Sayed, PhD
Regents' Professor and Julius Brown Chair School of Chemistry and Biochemistry Georgia Institute of Technology Atlanta, GA, USA
Nanotechnology Enables Hot Gold Nanorods to Kill Cancer Cells and to Stop Alive Sick Cells from Migrating to other Places in the Body
Prof. TOSSON A. MORSY
Department of Parasitology Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt General Secretary, Egyptian Society of Parasitology Editor, Egyptian Journal of Parasitology Formerly WHO/Consultant
CUTANEOUS LEISHMANIASIS PREDISPOSING TO HUMAN SKIN CANCER: FORTY YEARS LOCAL AND REGIONAL STUDIES
Prof. MAMDOOH GHONEUM, DSc, USA
Department of Surgery Charles Drew University of Medicine & Science Los Angeles County, California, USA
From Bench to Bedside: The Role of Arabinoxylan Rice Bran (MGN-3/Biobran) in Cancer Immunotherapy
Prof. Hisham Tawfiq
Prof. of Clinical Oncology Chairman, Clinical Oncology Department Faculty of Medicine, Tanta University Hospital Tanta University, Egypt
Highlight on the challenge meeting conventional anti-cancer therapy
Prof. Natarajan Muthusamy, DVM, PhD
Division of Hematology Department of Internal Medicine The Ohio State University, USA
Avoiding collateral Damage-Targeting targeted therapies in Leukemia
Prof. Hideki Kasuya MD, PhD, FACS
Nagoya University Graduate School of Medicine 65 Tsurumai-cho, Showa-ku, Nagoya Aichi, JAPAN
Clinical trial data using new anti-cancer drug C-REV, oncolytic herpes simplex virus
Prof. Yi ZHANG, M.D. & Ph.D
Director, Biotherapy Center Distinguished Professor at Cancer Center The First Affiliated Hospital of Zhengzhou University Henan, P.R. China
Dissecting tumor microenvironment for treatment of cancer
Prof. Shengdian Wang
Key Laboratory of Infection and Immunity Institute of Biophysics, Chinese Academy of Sciences Chinese Academy of Sciences Beijing, China
Targeting IL-21 to tumor-reactive T cells enhances anti-PD-1 antibody therapy

SELECTED TALKS

Speaker Talk
Prof. Ibrahim El-Tantawy El-Sayed
Prof. of Biochemistry Department of Chemistry Faculty of Science Menoufia University Shebin El Koom, Egypt Laboratory of Medicinal Chemistry and Laboratory of Medical Biochemistry, University of Antwerp, Universiteitsplein 1,B-2610 Antwerp, Belgium
Design and synthesis of selective diarylphosphonate Inhibitors for urokinase-type plasminogen activator with in vivo antimetastatic properties
Prof. Tarek Aboul-Fadl
Department of Medicinal Chemistry Faculty of Pharmacy Assiut University Assiut 71526, Egypt
Novel Non-Cyclooxygenase Inhibitory Derivatives of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) for Colorectal Cancer Chemoprevention
Prof. Dr. Nahla M. Shoukry
Prof. of Immunology and Parasitology Zoolgy Department Faculty of Science Suez University, Egypt
Using UniprotKP for Anti-Cancer Drug Discovery

SPECIAL SCIENTIFIC SESSION

"Role of Research Center of Excellence in Drug Discovery"

Speaker Talk
Prof. Doaa A. Ghareeb
Prof. of Biochemistry Director, Biological Screening and Preclinical Trial Lab Department of Biochemistry Faculty of Science, Alexandria University, Egypt Director, Pharmaceutical & Fermentation Industries Development Centre, City of Scientific Research and Technological Applications Burg Alarab, Alexandria, Egypt
Pharmaceutical and Fermentation Industries Development Center strategy for development a multi-targets therapeutic weapon against Alzheimer disease
Prof. Ahmed Mansour Alzohairy, PhD
Prof. of Genetics, Molecular Genetics Lab. Group leader, Genetics Department Faculty of Agriculture, Zagazig University, Egypt. Executive Manager and Founder, Egyptian Center of Bioinformatics & Genomics, Zagazig University, Egypt.
Using UniprotKP for Anti-Cancer Drug Discovery
Dr. Mahmoud ElHefnawi (PhD)
Prof. and Biomedical informatics Leader, Chemoinformatics group Department of Informatics and systems Founder, Centre of Excellence for Advanced Sciences The National Research Centre Senior Scientist and Associate Prof. Centre of Informatics, Nile University, Egypt
Development of microRNAs as anti-liver cancer therapeutics
Dr. Mohamed Attia
Prof. ofClinical Pathology Department of Clinical pathology Faculty of Medicine, Tanta University Director, Flow Cytometry Unit, Tanta University
The Role of Center of Excellence in Cancer Research in anti-cancer drug Discovery
Prof. Mohamed Elshanshoory
Prof. of Pediatrics and Director of Pediatric Hematology Unit Department of Pediatric, Faculty of Medicine Director, Cancer Genetic Signature Center Tanta University Educational Hospital, Tanta University, Egypt
Role of Cancer Genetic Signature Center in anti-cancer drug discovery
Dr. Fotouh R. Mansour
Department of Pharmaceutical Analytical Chemistry Pharmaceutical Services Center Faculty of Pharmacy Tanta University, Egypt,
The Role of Tanta University Pharmaceutical Services Center in Drug Discovery
Prof. Noha Awad
Prof. of Clinical Oncology and Epidemiology High Publich Health Institute Alexandria University, Alexandria, Egypt National Cooredinatior, Egyptian Network for Cancer Research
Role of Egyptian Network for Cancer Research in Drug Discovery
Prof. Tarek Mostafa
Prof. of Biochemistry Department of Biochemistry, Faculty of Science Director, Tanta University Central Research Laboratory Tanta University, Egypt
The role of Tanta University Central Research Laboratory in Drug Discovery
Address

Convention Center, Medical Campus, Tanta University,
Tanta, Egypt.

Contacts

+201062363911
eacr@unv.tanta.edu.eg

Follow Us